Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melander

Showing results (501-510 of 1,704) with videos related to

Pageof 171
Sort By:
Neuroscience Letters|January 2, 1987
Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminenceO Nordström, T Melander, T Hökfelt, et al.
Biomacromolecules|May 9, 2006
New approaches to the analysis of enzymatically hydrolyzed methyl cellulose. Part 1. Investigation of the influence of structural parameters on the extent of degradationRoland Adden, Claes Melander, Gunnar Brinkmalm, et al.
Biomacromolecules|May 9, 2006
New approaches to the analysis of enzymatically hydrolyzed methyl cellulose. Part 2. Comparison of various enzyme preparationsClaes Melander, Roland Adden, Gunnar Brinkmalm, et al.
Biomolecular NMR Assignments|December 25, 2012
Chemical shift assignments and secondary structure prediction of the C-terminal domain of the response regulator BfmR from Acinetobacter baumanniiAndrew L Olson, Richele J Thompson, Christian Melander, et al.
Diabetes, Obesity & Metabolism|March 21, 2002
The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucoseU Lindblad, K Lindwall, A Sjöstrand, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Benzodiazepine prescribing patterns in a high-prescribing Scandinavian communityA Ekedahl, J Lidbeck, T Lithman, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice. A cohort studyB Beermann, H Melander, J Säwe, et al.
Annals of Internal Medicine|February 1, 1993
What is the benefit of increasing the sulfonylurea dose?S Stenman, A Melander, P H Groop, et al.
Plos One|November 9, 2018
miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular diseaseWidet Gallo, Jonathan Lou S Esguerra, Lena Eliasson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 DiabetesFilip Ottosson, Einar Smith, Widet Gallo, et al.
Pageof 171

Showing results (501-510 of 1,704) with videos related to

Sort By:
Pageof 171
Neuroscience Letters|January 2, 1987
Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminenceO Nordström, T Melander, T Hökfelt, et al.
Biomacromolecules|May 9, 2006
New approaches to the analysis of enzymatically hydrolyzed methyl cellulose. Part 1. Investigation of the influence of structural parameters on the extent of degradationRoland Adden, Claes Melander, Gunnar Brinkmalm, et al.
Biomacromolecules|May 9, 2006
New approaches to the analysis of enzymatically hydrolyzed methyl cellulose. Part 2. Comparison of various enzyme preparationsClaes Melander, Roland Adden, Gunnar Brinkmalm, et al.
Biomolecular NMR Assignments|December 25, 2012
Chemical shift assignments and secondary structure prediction of the C-terminal domain of the response regulator BfmR from Acinetobacter baumanniiAndrew L Olson, Richele J Thompson, Christian Melander, et al.
Diabetes, Obesity & Metabolism|March 21, 2002
The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucoseU Lindblad, K Lindwall, A Sjöstrand, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Benzodiazepine prescribing patterns in a high-prescribing Scandinavian communityA Ekedahl, J Lidbeck, T Lithman, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice. A cohort studyB Beermann, H Melander, J Säwe, et al.
Annals of Internal Medicine|February 1, 1993
What is the benefit of increasing the sulfonylurea dose?S Stenman, A Melander, P H Groop, et al.
Plos One|November 9, 2018
miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular diseaseWidet Gallo, Jonathan Lou S Esguerra, Lena Eliasson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 DiabetesFilip Ottosson, Einar Smith, Widet Gallo, et al.
Pageof 171